Yui K, Ikemoto S, Goto K, Nishijima K, Yoshino T, Ishiguro T
Department of Psychiatry, Jichi Medical School, Tochigi, Japan.
Pharmacopsychiatry. 2002 Mar;35(2):62-71. doi: 10.1055/s-2002-25067.
In this study, we examined the relationship between increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic changes, and susceptibility to subsequent spontaneous recurrences of methamphetamine (MAP) psychosis (i.e., flashbacks). The subjects were 81 physically healthy females. Plasma monoamine metabolite levels were assayed in: 19 flashbackers, of whom 11 experienced a single flashback and 8 exhibited subsequent flashbacks; 20 non-flashbackers with a history of MAP psychosis; 8 subjects with persistent MAP psychosis; and 23 MAP users and 11 non-user controls. All 19 flashbackers had undergone frightening and stressful experiences during previous MAP use. Mild psychosocial stressors then triggered their flashbacks. During flashbacks, plasma norepinephrine levels increased, with a small increase in plasma levels of 3-methoxytyramine, which is an index of dopamine release. Among the 19 flashbackers, the 8 with subsequent episodes had increased NE levels and slightly increased 3-methoxytyramine levels, while the 11 with a single episode displayed small increases in norepinephrine and 3-methoxytyramine levels. Thus, noradrenergic hyperactivity and increased dopamine release in response to mild psychosocial stressors may be responsible for the development of flashbacks. Robust noradrenergic hyperactivity with slightly increased DA release in response to mild stress may induce susceptibility to subsequent flashbacks. Flashbacks and schizophrenia may share the pathophysiology of susceptibility to recurrence of paranoid-hallucinatory states such as stress sensitization, and also noradrenergic hyperactivity and enhanced DA release. Thus, flashbacks may provide an appropriate model of susceptibility to paranoid-hallucinatory states of schizophrenia. The model psychosis is a potential tool for validating basic neurobiological concepts thought to be related to the schizophrenia. A better understanding of the neurobiological mechanisms of susceptibility to recurrence could provide useful information in the development of strategies for preventing relapse.
在本研究中,我们考察了与去甲肾上腺素能亢进相关的应激敏感性增加和多巴胺能变化之间的关系,以及对甲基苯丙胺(MAP)精神病后续自发复发(即闪回)的易感性。研究对象为81名身体健康的女性。检测了以下几组人群的血浆单胺代谢物水平:19名有闪回现象者,其中11人经历了单次闪回,8人随后出现了闪回;20名有MAP精神病病史的无闪回者;8名患有持续性MAP精神病的受试者;23名MAP使用者和11名非使用者对照。所有19名有闪回现象者在之前使用MAP期间都经历过可怕且有压力的经历。随后,轻度的心理社会应激源引发了他们的闪回。在闪回期间,血浆去甲肾上腺素水平升高,作为多巴胺释放指标的血浆3 - 甲氧基酪胺水平略有升高。在这19名有闪回现象者中,8名后续有发作的患者去甲肾上腺素水平升高,3 - 甲氧基酪胺水平略有升高,而11名仅有单次发作的患者去甲肾上腺素和3 - 甲氧基酪胺水平有小幅升高。因此,对轻度心理社会应激源的去甲肾上腺素能亢进和多巴胺释放增加可能是闪回发生的原因。对轻度应激反应时强烈的去甲肾上腺素能亢进且多巴胺释放略有增加,可能会诱发对后续闪回的易感性。闪回和精神分裂症可能共享对偏执 - 幻觉状态复发的易感性的病理生理学机制,如应激敏感化,以及去甲肾上腺素能亢进和多巴胺释放增强。因此,闪回可能为精神分裂症偏执 - 幻觉状态的易感性提供一个合适的模型。这种模型精神病是验证被认为与精神分裂症相关的基本神经生物学概念的潜在工具。更好地理解复发易感性的神经生物学机制,可为制定预防复发策略提供有用信息。